Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Synvisc in Chinese Subjects With Symptomatic Osteoarthritis of the Knee
NCT01586338Phase 4Completed
- Sponsor
- Sanofi
- Start
- Mar 2012
- Primary completion
- Sep 2013
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of hylan in knee osteoarthritis (OA), sponsored by Sanofi. Started Mar 2012; status: completed.
02
Drugs
hylan
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT01586338.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01586338.